<SEC-DOCUMENT>0001477932-20-006714.txt : 20201117
<SEC-HEADER>0001477932-20-006714.hdr.sgml : 20201117
<ACCEPTANCE-DATETIME>20201117165903
ACCESSION NUMBER:		0001477932-20-006714
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20201117
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201117
DATE AS OF CHANGE:		20201117

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cosmos Holdings Inc.
		CENTRAL INDEX KEY:			0001474167
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				270611758
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-54436
		FILM NUMBER:		201321846

	BUSINESS ADDRESS:	
		STREET 1:		141 W. JACKSON BLVD
		STREET 2:		SUITE 4236
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60604
		BUSINESS PHONE:		312-536-3102

	MAIL ADDRESS:	
		STREET 1:		141 W. JACKSON BLVD
		STREET 2:		SUITE 4236
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60604

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIME ESTATES & DEVELOPMENTS INC
		DATE OF NAME CHANGE:	20091008
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cosm_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html><head><title>cosm_8k.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; </p> <table style="font-size:1px;width:100%"> <tr > <td style="BORDER-BOTTOM: 5px solid;"></td></tr> <tr > <td style="BORDER-BOTTOM: 2px solid;"></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><font style="font-size:12pt">UNITED STATES</font></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><font style="font-size:12pt">SECURITIES AND EXCHANGE COMMISSION</font></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><font style="font-size:12pt">Washington, D.C. 20549</font></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><font style="font-size:18pt">FORM 8-K</font></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CURRENT REPORT</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Date of Report (Date of earliest event reported) <strong>November 17, 2020</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:60%" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;width:98%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;"><strong><font style="font-size:18pt">Cosmos Holdings Inc.</font></strong></p></td></tr> <tr style="height:15px"> <td style="width:98%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">(Exact name of registrant as specified in its charter)</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;width:30%;"> <p style="MARGIN: 0px; text-align:center;"><strong>Nevada</strong></p></td> <td style="width:5%;"> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:30%;"> <p style="MARGIN: 0px; text-align:center;"><strong>000-54436&nbsp;</strong></p></td> <td style="width:5%;"> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:30%;"> <p style="MARGIN: 0px; text-align:center;"><strong>27-0611758&nbsp;</strong></p></td></tr> <tr style="height:15px"> <td> <p style="MARGIN: 0px; text-align:center;">(State or other jurisdiction</p> <p style="MARGIN: 0px; text-align:center;">of incorporation) </p></td> <td> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">(Commission</p> <p style="MARGIN: 0px; text-align:center;">File Number) </p></td> <td> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">(I.R.S. Employer</p> <p style="MARGIN: 0px; text-align:center;">Identification No.)</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-BOTTOM: 1px solid;width:45%;"> <p style="MARGIN: 0px; text-align:center;"><strong>141 West Jackson Blvd, Suite 4236,</strong></p> <p style="MARGIN: 0px; text-align:center;"><strong>Chicago, Illinois </strong></p></td> <td style="width:10%;"> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:45%;vertical-align:bottom;"> <p style="MARGIN: 0px; text-align:center;"><strong>60604</strong></p></td></tr> <tr style="height:15px"> <td> <p style="MARGIN: 0px; text-align:center;">(Address of principal executive offices)&nbsp;</p></td> <td> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td> <p style="MARGIN: 0px; text-align:center;">(Zip Code)</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Registrant&#8217;s telephone number, including area code <strong>(312) 865-0026</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><u>N/A</u></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Former name or former address, if changed since last report.)</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b of this chapter).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Emerging growth company &#9744;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;&nbsp;&nbsp;&nbsp;&nbsp; Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;&nbsp;&nbsp;&nbsp;&nbsp; Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;&nbsp;&nbsp;&nbsp;&nbsp; Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;&nbsp;&nbsp;&nbsp;&nbsp; Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="font-size:1px;width:100%"> <tr > <td style="BORDER-BOTTOM: 2px solid;"></td></tr> <tr > <td style="BORDER-BOTTOM: 5px solid;"></td></tr></table> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="TEXT-INDENT: 0px;"></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 2.02 Result of Operations and Financial Condition</strong>&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 17, 2020 Cosmos Holdings, Inc. (the &#8220;Company&#8221;) issued a press release announcing financial results for the third quarter of 2020. A copy of the press release titled &#8220;Cosmos Holdings, Inc. Reports Record Third Quarter and Nine-Month Financial Results&#8221; is attached hereto as Exhibit 99.1 and is incorporated herein by reference. This information is intended to be furnished under this Item 2.02 of Form 8-K and shall not be deemed &#8220;Filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934 as amended, (the &#8220;Exchange Act&#8221;), or incorporated by reference in any filing under the Securities Act of 1933 as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 9.01 Financial Statements and Exhibits</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(d) Exhibits.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;text-align:left;width:100%" cellpadding="0"> <tr style="height:15px;background-color:#cceeff"> <td style="width:10%;"> <p style="margin:0px"><a href="cosm_ex991.htm">Exhibit 99.1</a></p></td> <td style="width:2%;"> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px"><a href="cosm_ex991.htm">Press Release dated November 17, 2020</a></p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"> <p style="MARGIN: 0px; text-align:center;">2</p></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SIGNATURES</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="margin:0px"><strong>COSMOS HOLDINGS INC. </strong></p></td> <td></td></tr> <tr style="height:15px"> <td style="width:50%;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:3%;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:35%;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:12%;"> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">Date: November 17, 2020&nbsp;</p></td> <td> <p style="margin:0px">By:</p></td> <td style="BORDER-BOTTOM: 1px solid;"> <p style="margin:0px"><em>/s/ Grigorios Siokas</em></p></td> <td></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">Grigorios Siokas</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">Chief Executive Officer</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"> <p style="MARGIN: 0px; text-align:center;">3</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>cosm_ex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html><head><title>cosm_ex991.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 99.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="cosm_ex991img1.jpg"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Cosmos Holdings</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>+1 312 536 3102</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>info@cosmoshold.com</strong><strong> </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>141 West Jackson Blvd., Suite 4236</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Chicago, IL 60604</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>FOR IMMEDIATE RELEASE </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>COSMOS HOLDINGS, INC. REPORTS RECORD THIRD QUARTER </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>AND NINE-MONTH FINANCIAL RESULTS</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Revenue Increases 48%, Gross profit increased 210% to $2.39 million and Earnings Rise over Same 2019 Period</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Generics and Nutraceuticals Lead Expansion in Europe</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Robotic Automations Enhance Margins and Reduce Costs</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>CHICAGO, November 17, 2020 --</strong> Cosmos Holdings, Inc. (&#8220;the company") (OTCQ&#914;: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU distribution network, announced today record Third Quarter and Nine-Month results for the period ended September 30, 2020.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;font-variant:normal;font-weight:normal;font-style:normal;text-align:justify;margin-left:auto;line-height:normal;margin-right:auto;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;">Operating revenue rose 48 percent to $14.35 million from $9.68 million for the three months ended September 30, 2019; for the nine months, revenue increased 40 percent to $39.10 million from $27.88 million for the prior-year period.</td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;">Gross profit increased 210 percent to $2.39 million for the three months ended September 30, 2020; gross profit increased 213 percent to $5.93 million for the nine months ended September 30,2020, compared to $1.89 million gross profit for the prior-year period. The increase in gross profit is due to market growth of &#8220;Sky Premium Life&#8221; nutraceutical products.</td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;">The company had net income of $757 thousand, or $0.06 cents fully diluted earnings per share, for the three months ended September 30, 2020, versus a loss of $1.65 million, or $0.12 cents per share, for the three months ended September 30, 2019. For the nine months ended September 30, 2020, net income was $1.65 million, or $0.12 cents per share, compared to a loss of $3.39 million, or $0.26 cent a share for the same prior-year period.</td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;">The weighted average number of fully diluted shares was 13,263,944 for the three months ended September 30, 2020 versus 13,225,387 in 2019. The number of fully diluted shares was 13,260,518 for the nine months ended September 30, 2020 versus 13,289,843 for the same nine-month period in 2019.</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">1</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8220;These excellent results were planned by our management team with a focus on driving organic growth at attractive margins in our business,&#8221; said Greg Siokas, CEO of Cosmos Holdings, Inc. &#8220;All of our businesses are contributing to our rapid growth and expansion. We have created, developed and marketed a proprietary line of nutraceuticals, and this line of products will increase to 71 total by year-end. We have also significantly increased our distribution and sale of generic pharmaceuticals throughout Europe, with an increase in the number of distribution rights we hold to 47.&#8221; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8220;With the world fighting Covid-19 we were able to obtain exclusive distribution rights for delivery of the Copper Mask Type IIR for destruction of bacteria and viruses,&#8221; Siokas concluded. &#8220;We are also increasing our R&amp;D efforts to innovate and create new products for the ongoing battle against Covid-19. This has been a great year for us, and we expect to announce similar positive year-end results.&#8221;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Third Quarter/Nine-Month results for the period ended September 30, 2020 (unaudited)</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;border-right:#000000 1px solid;border-bottom:#000000 1px solid;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:27%;"> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:25%;vertical-align:top;" colspan="2"> <p style="MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:27%;vertical-align:top;" colspan="2"> <p style="MARGIN: 0px; text-align:center;"><strong>Nine Months Ended</strong></p></td></tr> <tr style="height:15px"> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:27%;"> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:25%;vertical-align:top;" colspan="2"> <p style="MARGIN: 0px; text-align:center;"><strong>September 30</strong></p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:27%;vertical-align:top;" colspan="2"> <p style="MARGIN: 0px; text-align:center;"><strong>September 30</strong></p></td></tr> <tr style="height:15px"> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:27%;"> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:13%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:12%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;"><strong>2019</strong></p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:14%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:14%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;"><strong>2019</strong></p></td></tr> <tr style="height:15px"> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:27%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:right;"><strong>Revenues</strong></p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:13%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">$14,352,098</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:12%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">$9,685,850</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:14%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">$39,105,318</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:14%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">$27,883,147</p></td></tr> <tr style="height:15px"> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:27%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:right;"><strong>Cost of Goods Sold</strong></p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:13%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">11,954,788</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:12%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">8,886,084</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:14%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">33,166,706</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:14%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">25,988,226</p></td></tr> <tr style="height:15px"> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:27%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:right;"><strong>Gross Profit</strong></p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:13%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">2,397,310</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:12%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">799,766</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:14%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">5,938,612</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:14%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">1,894,921</p></td></tr> <tr style="height:15px"> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:27%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:right;"><strong>Income from Operations</strong></p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:13%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">1,080,003</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:12%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">(116,562)</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:14%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">2,291,880</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:14%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">(816,192)</p></td></tr> <tr style="height:15px"> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:27%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:right;"><strong>Net Income (loss)</strong></p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:13%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">757,866</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:12%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">(1,633,349)</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:14%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">1,651,867</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:14%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">(3,390,555)</p></td></tr> <tr style="height:15px"> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:27%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:right;"><strong>Basic Net Income (Loss) Per share</strong></p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:13%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">$0.06</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:12%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">($0.12)</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:14%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">$0.12</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:14%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">($0.26)</p></td></tr> <tr style="height:15px"> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:27%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:right;"><strong>Diluted Net Income </strong></p> <p style="MARGIN: 0px; text-align:right;"><strong>( loss) Per share</strong></p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:13%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">$0.06</p> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:12%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">($0.12)</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:14%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">$0.12</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:14%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">($0.26)</p></td></tr> <tr style="height:15px"> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:79%;vertical-align:top;" colspan="5"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;"><strong>Weighted average number of Shares outstanding</strong></p> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:27%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:right;"><strong>Basic</strong></p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:13%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">13,225,387</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:12%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">13,225,387</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:14%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">13,225,387</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:14%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">13,289,843</p></td></tr> <tr style="height:15px"> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:27%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:right;"><strong>Diluted</strong></p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:13%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">13,263,944</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:12%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">13,225,387</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:14%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">13,260,518</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:14%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:center;">13,289,843</p></td></tr></table> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cosmos Holdings, Inc. is an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU distribution network. The company has direct access to Europe&#8217;s primary sales channels for pharmaceuticals and nutraceuticals and maintains relationships with 160+ pharmaceutical wholesale distributors in Europe&#8217;s largest markets. Cosmos Holdings, Inc. sells directly to 1,500 pharmacies, with access to more than 50,000 pharmacies throughout Europe. More information is available at www.cosmosholdingsinc.com. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 2, 2020, <u>Cosmos Holdings, Inc. announced seasoned entrepreneur David Lowenstein, 58, has agreed to join its board of directors</u>, and that the company has also entered into an advisory agreement with Mr. Lowenstein&#8217;s consulting business, Hyper Enterprises, an Ontario corporation to advise and assist with mergers, acquisitions, capital markets and strategy.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 16, 2020, <u>Cosmos Holdings, Inc. announced it had entered into an advisory agreement with PGS Ventures B.V. (PGS),</u> to advise the company on mergers &amp; acquisitions, financing and senior exchange listing strategies. Peter Goldstein, the Director and Principal of PGS, was appointed as Executive Director to the Cosmos Holdings, Inc. Board of Directors.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>About Cosmos Holdings, Inc.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cosmos Holdings Inc. is an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU distribution network. The company identifies, acquires, develops and commercializes products that improve patients' lives and outcomes. Cosmos Holdings has offices and distribution centers in Thessaloniki, Greece and Harlow, UK.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Press Release Disclaimer</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cosmos Holdings, Inc. takes no responsibility for updating the information contained in this press release following the date hereof to reflect events or circumstances occurring after the date hereof or the occurrence of unanticipated events or for any changes or modifications made to this press release or the information contained herein by any third-parties, including, but not limited to, any wire or internet services.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Forward-Looking Statements</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">With the exception of the historical information contained in this news release, the matters described herein may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements preceded by, followed by or that otherwise include the words &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221; &#8220;projects,&#8221; &#8220;estimates,&#8221; &#8220;plans&#8221; and similar expressions or future or conditional verbs such as &#8220;will,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;may&#8221; and &#8220;could&#8221; are generally forward-looking in nature and not historical facts, although not all forward-looking statements include the foregoing. These statements involve unknown risks and uncertainties that may individually or materially impact the matters discussed herein for a variety of reasons that are outside the control of the company, including, but not limited to, the company&#8217;s ability to raise sufficient financing to implement its business plan, the impact of the COVID-19 pandemic on the company&#8217;s business, operations and the economy in general, and the Company&#8217;s ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward- looking statements, as actual results could differ materially from those described in the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the company&#8217;s filings with the SEC, which are available at the SEC&#8217;s website (www.sec.gov). The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Investor Relations</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Michael J. Porter, President<br>Porter, LeVay &amp; Rose, Inc.<br>T: (973) 865-9357<br>E: mike@plrinvest.com</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">LinkedIn @PlRinvest</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>cosm_ex991img1.jpg
<TEXT>
begin 644 cosm_ex991img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1"  S )T# 2(  A$! Q$!_\0
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MZYV.WT'N*!GO/Q"UV\\+_#3Q!X@T]%:\L+.2:$.,J'QP2.X!.?PKRKX5^&?
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CU?6W@ VB% /0#T/%%% %/1O^0:S=VFG9CZGS&YK4HHH _]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
